Onychomycosis: drugs in the pipeline

Author： Lamers Christina   Merk Daniel   Schubert-Zsilavecz Manfred  

Publisher： Govi-Verlag

ISSN： 2195-2175

Source： PHARMAKON, Vol.2, Iss.3, 2014-05, pp. : 206-208

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Investigational drugs for onychomycosis

By Gupta Aditya K   Simpson Fiona C  

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 1, 2014-01 ,pp. : 97-106

Informa Healthcare

Access to resources Recommend Favorite

Antihypertensive drugs in the pipeline

By Lehmann Jochen  

PHARMAKON, Vol. 1, Iss. 5, 2013-09 ,pp. : 420-424

Govi-Verlag

Access to resources Recommend Favorite

Emerging pipeline drugs for hepatitis B infection

By Cox Natravis   Tillmann Hans  

Expert Opinion on Emerging Drugs, Vol. 16, Iss. 4, 2011-12 ,pp. : 713-729

Informa Healthcare

Access to resources Recommend Favorite

Filling the Pipeline - New Drugs for an Old Disease

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 1, 2014-01 ,pp. : 110-129

Bentham Science Publishers

Access to resources Recommend Favorite

Pipeline drugs influence future US drug spend

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 335, 2001-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite